advertisement
11.3.3 Apraclonidine, brimonidine (10)
Showing records 1 to 10
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine3603 Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes
Acheampong AA; Shackleton M; John B; Burke J; Wheeler L; Tang Liu D
DISPOS. Drug Metabolism and Disposition 2002; 30: 421-429
3604 The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma
Chen YF; Hung PT; Hsieh JW; Shein J; Hsiao CK
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 99-103
3605 A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial
Dubiner HB; Mroz M; Shapiro AM; Dirks MS
Clinical Therapeutics 2001; 23: 1969-1983
3606 Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells
Hua Gao; Xiaoxi Qiao; Cantor LB; WuDunn D
Archives of Ophthalmology 2002; 120: 797-803
3607 Inhibition by brimonidine of forskolin-induced nitrite production in isolated pig ciliary processes
Liu R; Wu R; Flammer J; Haefliger IO
Investigative Ophthalmology and Visual Science 2002; 43: 2727-2731
3608 Brimonidine 0.2% as a replacement for beta blockers in geriatric patients with glaucoma
Noecker RJ; Cantor L; Katz J; Katzman B; Kent A; LeBlanc R; Severin T
Advances in Therapy 2002; 19: 91-97
3609 Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy
Stewart WC; Stewart JA; Jackson AL
Acta Ophthalmologica Scandinavica 2002; 80: 277-281
3610 Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment
Titouamane S; Baudouin C
Journal Français d'Ophtalmologie 2002; 25: 568-75
3611 Delayed hypersensitivity to brimonidine tartrate 0.2% associated with high intraocular pressure
Watts P; Hawksworth N
Eye 2002; 16: 132-135
3612 Clinical research on 0.2% alphagan and 0.5% timolol in primary open-angle glaucoma and ocular hypertension
Zhong L; Li M
Chinese Ophthalmic Research 2002; 20: 153-156
